Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Martin Dreyling(LMU Klinikum), Eva Hoster(Zimmer Biomet (Germany)), Jeanette K. Doorduijn(Université Paris Cité), Georg Heß(Johannes Gutenberg University Mainz), Melania Celli(Ospedale Infermi di Rimini), Luca Arcaini(University of Pavia), Stephan Stilgenbauer(Universität Ulm), Matthias Hänel(San Antonio College), Christian Schmidt(Ludwig-Maximilians-Universität München), María Gomes da Silva(Instituto Português de Oncologia Francisco Gentil), Ron D. Jachimowicz(University Hospital Cologne), Mats Jerkeman(Lund University), Stefan Wirths(University of Tübingen), Jon Riise(Oslo University Hospital), Carlo Visco(University of Verona), Tom van Meerten(University Medical Center Groningen), Ulrich Mey(Kantonsspital Graubünden), Kristina Sonnevi(Karolinska Institutet), Linmiao Jiang(Zimmer Biomet (Germany)), Sirpa Leppä(University of Helsinki), Eva Giné(Aristotle University of Thessaloniki), Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), Fabio Benedetti(Azienda Ospedaliera Universitaria Integrata Verona), Ofer Shpilberg(Texas Oncology), Martin Hutchings(University of Copenhagen), Döndü Gözel(LMU Klinikum), Urban Novak(University of Bern), Marco Ladetto(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Andrea Kerkhoff(University Hospital Münster), Marek Trněný(The University of Texas System), Pier Luigi Zinzani(University of Bologna), Vibeke Vergote(KU Leuven), Wolfgang Hiddemann(Christian-Albrechts-Universität zu Kiel), Michael Unterhalt, Judith Dierlamm(Franklin University), Peter Herhaus(Technical University of Munich), Christiane Pott(University Hospital Schleswig-Holstein), Christine Hanoun(Essen University Hospital)
Cited by 135
Related Papers
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k